Related Experiment Video
Updated: Oct 15, 2025

A Package of Established Analytical Tools to Investigate the Solid-State Alteration of Lipid-Based Excipients
Published on: August 9, 2022
Amorphous Solid Dispersions (ASDs): The Influence of Material Properties, Manufacturing Processes and Analytical
Raman Iyer1, Vesna Petrovska Jovanovska2, Katja Berginc2
1Technical Research and Development, c/o Global Drug Development, Novartis Pharmaceuticals Corp., One Health Plaza, East Hanover, NJ 07936, USA.
Amorphous solid dispersions (ASDs) enhance oral drug absorption by improving solubility. This review covers ASD design, manufacturing, characterization, and the development of new polymers for improved bioavailability.
Area of Science:
- Pharmaceutical Science
- Drug Delivery
- Materials Science
Background:
- Poorly water-soluble drugs exhibit low oral absorption and bioavailability.
- Formulation strategies like amorphous solid dispersions (ASDs) enhance drug solubility and dissolution.
- ASDs are the most prevalent technology for solubility enhancement in marketed drugs (2000-2020).
Purpose of the Study:
- To review the scientific principles and influencing factors in designing amorphous solid dispersion (ASD) products.
- To discuss recent advancements in analytical techniques for ASD characterization and processability.
- To address the need for novel ASD polymers and the regulatory pathway for their development.
Main Methods:
- Review of scientific literature on amorphous solid dispersions.
- Discussion of factors influencing ASD selection and design (drug properties, materials, manufacturing).
- Overview of analytical tools for ASD stability and processability assessment.
Main Results:
- Amorphous solid dispersion technology is a key strategy for improving oral bioavailability of poorly soluble drugs.
- Successful ASD product development depends on understanding drug-excipient interactions, material properties, and manufacturing processes.
- Advanced analytical tools are crucial for characterizing ASDs and ensuring processability into patient-centric dosage forms.
Conclusions:
- Amorphous solid dispersions represent a mature and widely adopted technology for enhancing drug solubility and bioavailability.
- Further innovation in ASD polymers is needed, alongside clear regulatory guidance, to address unmet needs in drug development.
- Characterization and processability are critical for translating ASD technology into effective and patient-friendly medicines.
Related Concept Videos
Factors Influencing Drug Absorption: Pharmaceutical Parameters
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
Factors Affecting Dissolution: Particle Size and Effective Surface Area

